Literature DB >> 25496808

Synthesis of prenylated quinolinecarboxylic acid derivatives and their anti-obesity activities.

Haruhisa Kikuchi1, Toshiyuki Suzuki2, Masato Ogura2, Miwako K Homma2, Yoshimi Homma2, Yoshiteru Oshima3.   

Abstract

Mitochondrial uncoupling is one of the therapeutic strategies used to control energy metabolism in various metabolic diseases and in obesity. Ppc-1 (1), a prenylated quinolinecarboxylic acid isolated from cellular slime molds, shows uncoupling activity in vitro and anti-obesity activity in vivo. In this study, we synthesized Ppc-1 (1) and its derivatives, and revealed the structure-activity relationship of uncoupling activities. The triprenylated compound 18 showed mitochondrial uncoupling activity that was more potent than that of Ppc-1 (1). Compound 18 also suppressed weight gain in mice without undesired effects such as lesions on tissues. These results indicate that compound 18 could be used as a seed compound for new anti-obesity drugs.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-obesity drugs; Metabolic diseases; Mitochondrial uncoupling; Quinolinecarboxylate; Structure–activity relationship

Mesh:

Substances:

Year:  2014        PMID: 25496808     DOI: 10.1016/j.bmc.2014.11.024

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Prenylated quinolinecarboxylic acid compound-18 prevents sensory nerve fiber outgrowth through inhibition of the interleukin-31 pathway.

Authors:  Masato Ogura; Kumiko Endo; Toshiyuki Suzuki; Yoshimi Homma
Journal:  PLoS One       Date:  2021-02-04       Impact factor: 3.240

2.  Synthetic- and DFT modelling studies on regioselective modified Mannich reactions of hydroxy-KYNA derivatives.

Authors:  Bálint Lőrinczi; Antal Csámpai; Ferenc Fülöp; István Szatmári
Journal:  RSC Adv       Date:  2020-12-24       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.